Dr Martin Turner who's head of policy and public affairs at the BioIndustry Association tells Proactive London it's a golden age of biotech currently with many more people wanting to get involved and invest in the sector. He says for newcomers to the space it's important they familiarise themselves with the clinical trial process as well as the different types of therapies and the science behind them. He says that as traditional sectors continue to suffer with the market disruption brought about by coronavirus, biopharma and healthcare is one of the few economic sectors to have largely escaped the global downturn.
BioIndustry Association marks 'golden age of biotech'
Quick facts: Avacta Group PLC
Price: 129 GBX
Market Cap: £325.92 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Avacta Group PLC named herein, including the promotion by the Company of Avacta Group PLC in any Content on the Site, the Company receives from...FOR OUR FULL DISCLAIMER CLICK HERE